Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications

Pharmacology & Therapeutics
M R PicciottoS L King

Abstract

Nicotinic acetylcholine receptors (nAChRs) in the muscle, autonomic ganglia, and brain are targets for pharmacologically administered nicotine. Several of the subunits that combine to form neuronal nicotinic receptors have been deleted by knockout or mutated by knockin in mice using homologous recombination. We will review the biochemical, pharmacological, anatomical, physiological, and behavioral phenotypes of mice with genetically altered neuronal nAChR subunits. Clinically relevant mutations in nAChR genes will also be discussed. In addition, some of the signal transduction pathways activated through nAChRs will be described in order to delineate the longer-term changes that might result from persistent activation or inactivation of nAChRs. Genetically manipulated mice have greatly increased our understanding of the subunit composition and physiological properties of nAChRs in vivo. In addition, these mice have provided a model system to determine the molecular basis for many of the pharmacological actions of nicotine on neurotransmitter release and behavior. Genetic manipulations in mice have also elucidated the role of nAChR subunits in various disease states, and suggest several avenues for drug development.

References

May 1, 1992·Journal of Neurochemistry·R K TuominenJ S Hong
Jun 22, 1991·BMJ : British Medical Journal·C M van Duijn, A Hofman
Jul 1, 1989·Pharmacology, Biochemistry, and Behavior·M J MarksA C Collins
May 1, 1989·Pharmacology, Biochemistry, and Behavior·B CostallE S Onaivi
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J GiraudatJ P Changeux
Nov 1, 1986·Neurology·J A Baron
Feb 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·T ClaudioS Heinemann
Aug 1, 1995·Brain Research. Molecular Brain Research·T C MadhokB M Sharp
May 10, 1995·Annals of the New York Academy of Sciences·S L SwopeR L Huganir
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D BertrandJ P Changeux
May 19, 1995·The Journal of Biological Chemistry·P J CorringerD Bertrand
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·C CzajkowskiA Karlin
Jul 6, 1993·European Journal of Pharmacology·J D BrioniM W Decker
Aug 1, 1993·Pharmacology, Biochemistry, and Behavior·W CaoA C Collins
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P DaubasJ P Changeux
Aug 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·K E StevensG M Rose

❮ Previous
Next ❯

Citations

Nov 19, 2002·Journal of Neurobiology·Young-Hwan JoLorna W Role
Nov 18, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alessandro GozziAngelo Bifone
Oct 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·R SattaA Guidotti
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Inmaculada Ballesteros-YáñezJavier DeFelipe
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Boris B QuednowGeorg Winterer
Sep 6, 2008·Journal of Applied Physiology·Denys V VolginLeszek Kubin
Jul 29, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tresa M McGranahanT K Booker
Oct 5, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jennifer A DavisThomas J Gould
Jan 11, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xuesi M ShaoJack L Feldman
Jun 28, 2014·Neurochemical Research·J Alex Grizzell, Valentina Echeverria
Feb 4, 2014·Biochemical Pharmacology·Roger L Papke
Jan 18, 2012·Psychopharmacology·Renata dos Santos Coura, Sylvie Granon
Jan 15, 2014·Cellular and Molecular Life Sciences : CMLS·Boris B QuednowMoritz J Rossner
Jun 19, 2004·The British Journal of Ophthalmology·S-M SawR A Stone
May 12, 2015·The Journal of Veterinary Medical Science·Tetsushi HiranoNobuhiko Hoshi
Aug 1, 2008·Pathology, Research and Practice·Hervé SarteletPhilippe Birembaut
Jun 3, 2008·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Hossein Mehrani, Leila Golmanesh
Aug 11, 2007·Biochemical Pharmacology·Bruce E McKayJohn A Dani
Jun 29, 2007·Biochemical Pharmacology·Cecilia GottiMichele Zoli
Dec 19, 2006·American Journal of Preventive Medicine·Uma Rao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.